Last $7.42 USD
Change Today -0.11 / -1.46%
Volume 17.0K
GNCA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George R. Siber M.D.

Chairman of Scientific Advisory Board, Executive Director and Member of Compensation Committee, Genocea Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 90 board members in 8 different organizations across 8 different industries.

See Board Relationships
70$179,255

Background*

Dr. George R. Siber, M.D., serves as Chief Scientific Officer of ClearPath Development Company. Dr. Siber served as the Chief Scientific Officer and Executive Vice President of Wyeth Vaccines, Ltd. Dr. Siber oversaw the development and approval of multiple widely-used childhood vaccines including an acellular pertussis vaccine (Acel-Imune), a meningococcal meningitis vaccine (Meningitec), and a pneumococcal vaccine (Prevnar). He served as Associate Professor of Medicine ...

Read Full Background

Corporate Headquarters*

100 Acorn Park Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-876-8191
Fax: --

Board Members Memberships*

Director and Member of Scientific Advisory Board
Director
2007-Present
Chairman of Scientific Advisory Board, Executive Director and Member of Compensation Committee
2013-Present
Trustee

Education*

MD
McGill University
Unknown/Other Education
Bishop's University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$124,992
Total Calculated Compensation$179,255
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNCA:US $7.42 USD -0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOCEA BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.